Purchases and Sales Made in Q1 2024 in Pharvaris N.V. (PHVS)
This table provides information about the institutional ownership of Pharvaris N.V. (PHVS) during Q1 2024. The information is specifically focused on institutions that hold shares of Pharvaris N.V..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 15, 2024
Q1 2024
|
General Atlantic LLC
New York, NY |
BUY
|
- |
1.38M+ 22.34% |
$29.2M - $44.1M
|
7.53M
$139M
|
|
|
May 15, 2024
Q1 2024
|
Commodore Capital LP
New York, NY |
BUY
|
- |
925K+ 115.63% |
$19.7M - $29.7M
|
1.73M
$31.9M
|
|
|
May 15, 2024
Q1 2024
|
Rock Springs Capital Management LP
Baltimore, MD |
BUY
|
- |
753KNew |
$16M - $24.1M
|
753K
$13.9M
|
|
|
May 15, 2024
Q1 2024
|
Deerfield Management Company, L.P. (Series C)
New York, NY |
BUY
|
- |
249K+ 30.7% |
$5.3M - $8M
|
1.06M
$19.6M
|
|
|
May 15, 2024
Q1 2024
|
Soleus Capital Management, L.P.
Greenwich, CT |
BUY
|
- |
185K+ 84.87% |
$3.92M - $5.92M
|
402K
$7.44M
|
|
|
May 15, 2024
Q1 2024
|
Sphera Funds Management Ltd.
Tel Aviv, L3 |
BUY
|
- |
148K+ 60.36% |
$3.14M - $4.74M
|
393K
$7.27M
|
|
|
May 08, 2024
Q1 2024
|
Td Asset Management Inc
|
BUY
|
- |
113KNew |
$2.39M - $3.61M
|
113K
$2.08M
|
|
|
May 15, 2024
Q1 2024
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
BUY
|
- |
96.8K+ 68.46% |
$2.06M - $3.11M
|
238K
$4.41M
|
|
|
May 15, 2024
Q1 2024
|
Sofinnova Investments, Inc.
Menlo Park, CA |
BUY
|
- |
74.2K+ 14.54% |
$1.58M - $2.38M
|
585K
$10.8M
|
|
|
May 15, 2024
Q1 2024
|
Goldman Sachs Group Inc
New York, NY |
BUY
|
- |
22.6K+ 263.97% |
$480K - $724K
|
31.1K
$576K
|
|
|
May 15, 2024
Q1 2024
|
Walleye Capital LLC
Plymouth, MN |
BUY
|
- |
19.3K+ 24.8% |
$411K - $619K
|
97.2K
$1.8M
|
|
|
May 15, 2024
Q1 2024
|
High Vista Strategies LLC
Boston, MA |
BUY
|
- |
16.8KNew |
$356K - $537K
|
16.8K
$310K
|
|
|
May 13, 2024
Q1 2024
|
Jump Financial, LLC
Chicago, IL |
BUY
|
- |
11.7KNew |
$249K - $375K
|
11.7K
$216K
|
|
|
May 13, 2024
Q1 2024
|
Geode Capital Management, LLC
Boston, MA |
BUY
|
- |
9.63K+ 44.59% |
$205K - $309K
|
31.2K
$578K
|
|
|
May 15, 2024
Q1 2024
|
Bank Of America Corp
Charlotte, NC |
BUY
|
- |
7.81KNew |
$166K - $250K
|
7.81K
$144K
|
|
|
May 15, 2024
Q1 2024
|
Morgan Stanley
New York, NY |
BUY
|
- |
6.55K+ 29.14% |
$139K - $210K
|
29K
$537K
|
|
|
Aug 16, 2024
Q1 2024
|
Morgan Stanley
New York, NY |
BUY
|
- |
6.55K+ 29.14% |
$139K - $210K
|
29K
$537K
|
|
|
Oct 17, 2024
Q1 2024
|
Morgan Stanley
New York, NY |
BUY
|
- |
5.75K+ 24.66% |
$122K - $184K
|
29K
$537K
|
|
|
May 10, 2024
Q1 2024
|
Jpmorgan Chase & CO
New York, NY |
BUY
|
- |
2.96K+ 1557.89% |
$62.9K - $94.9K
|
3.15K
$58.3K
|
|
|
May 15, 2024
Q1 2024
|
Adar1 Capital Management, LLC
Austin, TX |
BUY
|
- |
2KNew |
$42.5K - $64.1K
|
2K
$37K
|
|
|
Apr 30, 2024
Q1 2024
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
May 15, 2024
Q1 2024
|
Marshall Wace, LLP
London, X0 |
SELL
|
- |
-1.96K- 3.25% |
$41.6K - $62.7K
|
58.2K
$1.08M
|
|
|
May 14, 2024
Q1 2024
|
Qube Research & Technologies LTD
London, X0 |
SELL
|
- |
-2.18K- 6.75% |
$46.3K - $69.9K
|
30.1K
$558K
|
|
|
May 15, 2024
Q1 2024
|
Viking Global Investors LP
|
SELL
|
- |
-3.61K- 0.1% |
$76.8K - $116K
|
3.65M
$67.6M
|
|
|
Aug 14, 2024
Q1 2024
|
Sofinnova Investments, Inc.
Menlo Park, CA |
SELL
|
- |
-16.9K- 2.8% |
$358K - $541K
|
585K
$10.8M
|
|
|
May 15, 2024
Q1 2024
|
Hudson Bay Capital Management LP
Greenwich, CT |
SELL
|
- |
-50.1K- 71.46% |
$1.07M - $1.61M
|
20K
$370K
|
|
|
May 15, 2024
Q1 2024
|
Price T Rowe Associates Inc
Baltimore, MD |
SELL
|
- |
-84.8K- 10.06% |
$1.8M - $2.72M
|
758K
$14M
|
|
|
May 15, 2024
Q1 2024
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-168K- 89.11% |
$3.57M - $5.39M
|
20.5K
$380K
|
|
|
May 15, 2024
Q1 2024
|
Novo Holdings
Hellerup, G7 |
SELL
|
- |
-371K- 24.12% |
$7.89M - $11.9M
|
1.17M
$21.6M
|
|
|
May 15, 2024
Q1 2024
|
Bain Capital Life Sciences Investors, LLC
Boston, MA |
SELL
|
- |
-601K- 15.39% |
$12.8M - $19.3M
|
3.3M
$61.1M
|
|
|
May 15, 2024
Q1 2024
|
Ven Bio Partners LLC
San Francisco, CA |
SELL
|
- |
-630K- 12.81% |
$13.4M - $20.2M
|
4.29M
$79.4M
|